title: Cannabinoid concentrations in Canada's regulated medical cannabis industry.
authors.affiliation: Centre for Addiction and Mental Health, Institute for Mental Health Policy Research, 33 Russell street, Toronto, ON M5S 2S1, Canada.
authors.forename: George
authors.initials: G
authors.lastname: Mammen
authors.affiliation: Centre for Addiction and Mental Health, Institute for Mental Health Policy Research, 33 Russell street, Toronto, ON M5S 2S1, Canada.
authors.forename: Lauren
authors.initials: L
authors.lastname: de Freitas
authors.affiliation: Centre for Addiction and Mental Health, Institute for Mental Health Policy Research, 33 Russell street, Toronto, ON M5S 2S1, Canada.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Rehm
authors.affiliation: Centre for Addiction and Mental Health, Institute for Mental Health Policy Research, 33 Russell street, Toronto, ON M5S 2S1, Canada.
authors.forename: Sergio
authors.initials: S
authors.lastname: Rueda
mesh_terms: D002170:Canada; D002185:Cannabidiol; D002186:Cannabinoids; D002188:Cannabis; D013759:Dronabinol; D064086:Medical Marijuana
chemical_list: D002186:Cannabinoids; D064086:Medical Marijuana; D002185:Cannabidiol; D013759:Dronabinol
keywords: Cannabidiol; cannabinoid; delta-9-tetrahydrocannabinol; medical cannabis; monitoring; potency